"As a state-designated acute care children’s hospital, The Children’s Hospital at Saint Peter’s University Hospital offers a full-range of pediatric specialized healthcare services for newborns and children through young adulthood. The Children’s Hospital at Saint Peter’s operates one of the largest, most advanced neonatal intensive care units in the country. Our state-designated Regional Perinatal Center is renowned throughout New Jersey for the exceptional level of high-risk maternity and neonatal care provided."

During the past decade, Saint Peter's University Hospital conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 75 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 35 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Peter's University Hospital" #1 sponsor was "Children's Oncology Group" with 61 trials, followed by "National Cancer Institute (NCI)" with 40 trials sponsored, "Radiation Therapy Oncology Group" with 11 trials sponsored, "Rutgers, The State University of New Jersey" with 8 trials sponsored and "Alliance for Clinical Trials in Oncology" with 8 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Peter's University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 104 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "Children's Oncology Group" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 129 different institutions and companies that were collaborators in the rest 116 trials.

According to Clinical.Site data, the most researched conditions in "Saint Peter's University Hospital" are "Recurrent Neuroblastoma" (13 trials), "Refractory Neuroblastoma" (11 trials), "Refractory Non-Hodgkin Lymphoma" (11 trials), "Breast Cancer" (10 trials) and "Recurrent Hepatoblastoma" (10 trials). Many other conditions were trialed in "Saint Peter's University Hospital" in a lesser frequency.

Most popular intervention types in "Saint Peter's University Hospital" are "Drug" (129 trials), "Other" (88 trials), "Radiation" (49 trials), "Procedure" (43 trials) and "Biological" (40 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Cyclophosphamide" (32 trials), "Vincristine Sulfate" (26 trials), "Doxorubicin Hydrochloride" (24 trials) and "Radiation Therapy" (20 trials). Other intervention names were less common.

The vast majority of trials in "Saint Peter's University Hospital" are 147 trials for "All" genders, 36 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Peter's University Hospital". undefined are not yet recruiting, 38 are recruiting, 53 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 81 completed trials in Saint Peter's University Hospital, 2 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Peter's University Hospital, 4 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 13 trials that are defined as “Not Applicable".

Saint Peter's University Hospital has several departments that took part in Clinical trials: "Children's Hospital at Saint Peter's University Hospital" - 4 trials, "Childrens Hospital at Saint Peters University Hospital - Allergy, Immunology and Infectious Diseases" - 2 trials